Literature DB >> 22350529

Successful pregnancy following a novel endometrial preparation in a PCOS patient undergoing IVM: a case report.

Maryam Eftekhar1, Mohammad Ali Khalili, Abbas Aflatoonian, Navid Esfandiari.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350529      PMCID: PMC3309990          DOI: 10.1007/s10815-012-9723-0

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


× No keyword cloud information.
  11 in total

Review 1.  Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries.

Authors:  Weon-Young Son; Seang Lin Tan
Journal:  Hum Reprod Update       Date:  2010-05-26       Impact factor: 15.610

Review 2.  Controversies in IVM.

Authors:  Shauna Leigh Reinblatt; Weon-Young Son; Einat Shalom-Paz; Hananel Holzer
Journal:  J Assist Reprod Genet       Date:  2011-05-10       Impact factor: 3.412

Review 3.  In vitro maturation of human oocytes.

Authors:  Yu-Hung Lin; Jiann-Loung Hwang
Journal:  Taiwan J Obstet Gynecol       Date:  2006-06       Impact factor: 1.705

4.  Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome.

Authors:  Michel De Vos; Carolina Ortega-Hrepich; Firas K Albuz; Luis Guzman; Nikolaos P Polyzos; Johan Smitz; Paul Devroey
Journal:  Fertil Steril       Date:  2011-08-24       Impact factor: 7.329

5.  In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience.

Authors:  A Le Du; I J Kadoch; N Bourcigaux; S Doumerc; M-C Bourrier; N Chevalier; R Fanchin; R-C Chian; G Tachdjian; R Frydman; N Frydman
Journal:  Hum Reprod       Date:  2004-11-04       Impact factor: 6.918

Review 6.  Strategies in human in-vitro maturation and their clinical outcome.

Authors:  Anne Lis Mikkelsen
Journal:  Reprod Biomed Online       Date:  2005-05       Impact factor: 3.828

7.  Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study.

Authors:  R Fadini; M B Dal Canto; M Mignini Renzini; F Brambillasca; R Comi; D Fumagalli; M Lain; M Merola; R Milani; E De Ponti
Journal:  Reprod Biomed Online       Date:  2009-09       Impact factor: 3.828

8.  Combination of FSH priming and hCG priming for in-vitro maturation of human oocytes.

Authors:  Yu-Hung Lin; Jiann-Loung Hwang; Lee-Wen Huang; Shu-Chi Mu; Kok-Min Seow; Jesse Chung; Bih-Chwen Hsieh; Shih-Chia Huang; Chin-Yu Chen; Pei-Hsin Chen
Journal:  Hum Reprod       Date:  2003-08       Impact factor: 6.918

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining.

Authors:  Shai E Elizur; Weon-Young Son; Raymond Yap; Yariv Gidoni; Dan Levin; Ezgi Demirtas; Seang-Lin Tan
Journal:  Fertil Steril       Date:  2008-10-30       Impact factor: 7.329

View more
  2 in total

1.  Effect of Human Testicular Cells Conditioned Medium on In Vitro Maturation and Morphology of Mouse Oocytes.

Authors:  Maryam Adib; Seyed Morteza Seifati; Mahmood Dehghani Ashkezari; Fatemeh Akyash; Arezoo Khoradmehr; Behrouz Aflatoonian
Journal:  Int J Fertil Steril       Date:  2020-10-12

Review 2.  Contribution of human oocyte architecture to success of in vitro maturation technology.

Authors:  Mohammad Ali Khalili; Stefania A Nottola; Abbas Shahedi; Guido Macchiarelli
Journal:  Iran J Reprod Med       Date:  2013-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.